$ABBV Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in AbbVie Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in AbbVie Inc.. Get notifications about new insider transactions in AbbVie Inc. for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 12 2021 | ABBV | AbbVie Inc. | Strom Carrie C | SVP & Pres Global A ... | Payment of Exercise | F | 116.22 | 2,887 | 335,527 | 56,104 | 59 K to 56.1 K (-4.89 %) |
| May 11 2021 | ABBV | AbbVie Inc. | WADDELL FREDERICK H | Director | Grant | A | 0.00 | 1,681 | 0 | 23,562 | 21.9 K to 23.6 K (+7.68 %) |
| May 11 2021 | ABBV | AbbVie Inc. | TILTON GLENN F | Director | Grant | A | 0.00 | 1,681 | 0 | 46,168 | 44.5 K to 46.2 K (+3.78 %) |
| May 11 2021 | ABBV | AbbVie Inc. | Roberts Rebecca B | Director | Grant | A | 0.00 | 1,681 | 0 | 8,332 | 6.7 K to 8.3 K (+25.27 %) |
| May 11 2021 | ABBV | AbbVie Inc. | RAPP EDWARD J | Director | Grant | A | 0.00 | 1,681 | 0 | 27,163 | 25.5 K to 27.2 K (+6.60 %) |
| May 11 2021 | ABBV | AbbVie Inc. | MEYER MELODY B | Director | Grant | A | 0.00 | 1,681 | 0 | 11,102 | 9.4 K to 11.1 K (+17.84 %) |
| May 11 2021 | ABBV | AbbVie Inc. | Hart Brett J | Director | Grant | A | 0.00 | 1,681 | 0 | 14,076 | 12.4 K to 14.1 K (+13.56 %) |
| May 11 2021 | ABBV | AbbVie Inc. | LIDDY EDWARD M | Director | Grant | A | 0.00 | 1,681 | 0 | 26,683 | 25 K to 26.7 K (+6.72 %) |
| May 11 2021 | ABBV | AbbVie Inc. | FREYMAN THOMAS C | Director | Grant | A | 0.00 | 1,681 | 0 | 121,355 | 119.7 K to 121.4 K (+1.40 %) |
| May 11 2021 | ABBV | AbbVie Inc. | BURNSIDE WILLIAM H.L. | Director | Grant | A | 0.00 | 1,681 | 0 | 21,562 | 19.9 K to 21.6 K (+8.46 %) |
| May 11 2021 | ABBV | AbbVie Inc. | AUSTIN ROXANNE S | Director | Grant | A | 0.00 | 1,681 | 0 | 121,128 | 119.4 K to 121.1 K (+1.41 %) |
| May 11 2021 | ABBV | AbbVie Inc. | Alpern Robert J | Director | Grant | A | 115.96 | 1,681 | 194,929 | 30,121 | 28.4 K to 30.1 K (+5.91 %) |
| May 11 2021 | ABBV | AbbVie Inc. | Strom Carrie C | SVP & Pres Global A ... | Payment of Exercise | F | 116.08 | 234 | 27,163 | 58,991 | 59.2 K to 59 K (-0.40 %) |
| May 05 2021 | ABBV | AbbVie Inc. | Strom Carrie C | SVP & Pres Global A ... | Option Exercise | M | 41.39 | 4,184 | 173,176 | 0 | |
| May 05 2021 | ABBV | AbbVie Inc. | Strom Carrie C | SVP & Pres Global A ... | Sell | S | 112.40 | 4,184 | 470,282 | 59,225 | 63.4 K to 59.2 K (-6.60 %) |
| May 05 2021 | ABBV | AbbVie Inc. | Strom Carrie C | SVP & Pres Global A ... | Buy | M | 41.39 | 4,184 | 173,176 | 63,409 | 59.2 K to 63.4 K (+7.06 %) |
| Apr 01 2021 | ABBV | AbbVie Inc. | Alpern Robert J | Director | Option Exercise | A | 108.22 | 66 | 7,143 | 7,764 | |
| Apr 01 2021 | ABBV | AbbVie Inc. | LIDDY EDWARD M | Director | Option Exercise | A | 108.22 | 311 | 33,656 | 28,094 | |
| Apr 01 2021 | ABBV | AbbVie Inc. | RAPP EDWARD J | Director | Option Exercise | A | 108.22 | 325 | 35,172 | 19,855 | |
| Mar 09 2021 | ABBV | AbbVie Inc. | Strom Carrie C | SVP & Pres Global A ... | Payment of Exercise | F | 106.70 | 123 | 13,124 | 59,225 | 59.3 K to 59.2 K (-0.21 %) |
| Mar 09 2021 | ABBV | AbbVie Inc. | Strom Carrie C | SVP & Pres Global A ... | Payment of Exercise | F | 106.70 | 356 | 37,985 | 59,348 | 59.7 K to 59.3 K (-0.60 %) |
| Mar 09 2021 | ABBV | AbbVie Inc. | Strom Carrie C | SVP & Pres Global A ... | Payment of Exercise | F | 105.65 | 448 | 47,331 | 59,704 | 60.2 K to 59.7 K (-0.74 %) |
| Mar 02 2021 | ABBV | AbbVie Inc. | Gosebruch Henry O | EVP, Chief Strategy ... | Payment of Exercise | F | 107.74 | 22,833 | 2,460,027 | 48,711 | 71.5 K to 48.7 K (-31.91 %) |
| Mar 02 2021 | ABBV | AbbVie Inc. | Michael Robert A. | EVP, Chief Financia ... | Payment of Exercise | F | 107.74 | 14,006 | 1,509,006 | 37,877 | 51.9 K to 37.9 K (-27.00 %) |
| Mar 02 2021 | ABBV | AbbVie Inc. | RICHMOND TIMOTHY J. | EVP, Chief HR Offic ... | Sell | S | 108.59 | 19,514 | 2,119,041 | 0 | 19.5 K to 0 (-100.00 %) |
| Mar 02 2021 | ABBV | AbbVie Inc. | RICHMOND TIMOTHY J. | EVP, Chief HR Offic ... | Payment of Exercise | F | 107.74 | 15,524 | 1,672,556 | 19,514 | 35 K to 19.5 K (-44.31 %) |
| Mar 02 2021 | ABBV | AbbVie Inc. | SALEKI-GERHARDT AZITA | EVP, Operations | Payment of Exercise | F | 107.74 | 15,785 | 1,700,676 | 116,284 | 132.1 K to 116.3 K (-11.95 %) |
| Mar 02 2021 | ABBV | AbbVie Inc. | Sorg Elaine K. | SVP, US Commercial ... | Sell | S | 108.61 | 4,221 | 458,437 | 17,595 | 21.8 K to 17.6 K (-19.35 %) |
| Mar 02 2021 | ABBV | AbbVie Inc. | Sorg Elaine K. | SVP, US Commercial ... | Sell | S | 108.61 | 4,219 | 458,205 | 21,816 | 26 K to 21.8 K (-16.21 %) |
| Mar 02 2021 | ABBV | AbbVie Inc. | Sorg Elaine K. | SVP, US Commercial ... | Payment of Exercise | F | 107.74 | 6,716 | 723,582 | 26,035 | 32.8 K to 26 K (-20.51 %) |
| Mar 02 2021 | ABBV | AbbVie Inc. | Durkin Brian L | VP, Controller | Payment of Exercise | F | 107.74 | 2,392 | 257,714 | 21,115 | 23.5 K to 21.1 K (-10.18 %) |
| Mar 02 2021 | ABBV | AbbVie Inc. | Hudson Thomas J | SVP, R&D and CSO | Payment of Exercise | F | 107.74 | 7,740 | 833,908 | 29,372 | 37.1 K to 29.4 K (-20.86 %) |
| Mar 02 2021 | ABBV | AbbVie Inc. | GONZALEZ RICHARD A | Chairman of the Boa ... | Option Exercise | M | 0.00 | 170,113 | 0 | 0 | |
| Mar 02 2021 | ABBV | AbbVie Inc. | GONZALEZ RICHARD A | Chairman of the Boa ... | Sell | S | 109.33 | 631 | 68,984 | 376,597 | 377.2 K to 376.6 K (-0.17 %) |
| Mar 02 2021 | ABBV | AbbVie Inc. | GONZALEZ RICHARD A | Chairman of the Boa ... | Sell | S | 108.61 | 169,482 | 18,407,220 | 377,228 | 546.7 K to 377.2 K (-31.00 %) |
| Mar 02 2021 | ABBV | AbbVie Inc. | GONZALEZ RICHARD A | Chairman of the Boa ... | Buy | M | 54.86 | 170,113 | 9,332,399 | 546,710 | 376.6 K to 546.7 K (+45.17 %) |
| Mar 02 2021 | ABBV | AbbVie Inc. | GONZALEZ RICHARD A | Chairman of the Boa ... | Payment of Exercise | F | 107.74 | 74,384 | 8,014,132 | 376,597 | 451 K to 376.6 K (-16.49 %) |
| Mar 02 2021 | ABBV | AbbVie Inc. | GONZALEZ RICHARD A | Chairman of the Boa ... | Gift | G | 0.00 | 3,325 | 0 | 450,981 | 454.3 K to 451 K (-0.73 %) |
| Mar 02 2021 | ABBV | AbbVie Inc. | Stewart Jeffrey Ryan | SVP, US Commercial ... | Sell | S | 108.59 | 13,773 | 1,495,576 | 50,969 | 64.7 K to 51 K (-21.27 %) |
| Mar 02 2021 | ABBV | AbbVie Inc. | Stewart Jeffrey Ryan | SVP, US Commercial ... | Payment of Exercise | F | 107.74 | 10,957 | 1,180,507 | 64,742 | 75.7 K to 64.7 K (-14.47 %) |
| Mar 02 2021 | ABBV | AbbVie Inc. | SEVERINO MICHAEL | Vice Chairman | Payment of Exercise | F | 107.74 | 29,077 | 3,132,756 | 103,835 | 132.9 K to 103.8 K (-21.88 %) |
| Mar 02 2021 | ABBV | AbbVie Inc. | Schumacher Laura J | Vice Chairman | Payment of Exercise | F | 107.74 | 29,203 | 3,146,331 | 214,253 | 243.5 K to 214.3 K (-12.00 %) |
| Mar 02 2021 | ABBV | AbbVie Inc. | Strom Carrie C | SVP & Pres Global A ... | Payment of Exercise | F | 108.41 | 810 | 87,812 | 60,152 | 61 K to 60.2 K (-1.33 %) |
| Feb 24 2021 | ABBV | AbbVie Inc. | Sorg Elaine K. | SVP, US Commercial ... | Option Exercise | M | 79.02 | 5,192 | 410,272 | 5,192 | |
| Feb 24 2021 | ABBV | AbbVie Inc. | Sorg Elaine K. | SVP, US Commercial ... | Option Exercise | M | 93.50 | 15,003 | 1,402,781 | 30,005 | |
| Feb 24 2021 | ABBV | AbbVie Inc. | Sorg Elaine K. | SVP, US Commercial ... | Sell | S | 105.28 | 200 | 21,056 | 32,751 | 33 K to 32.8 K (-0.61 %) |
| Feb 24 2021 | ABBV | AbbVie Inc. | Sorg Elaine K. | SVP, US Commercial ... | Sell | S | 104.71 | 19,995 | 2,093,676 | 32,951 | 52.9 K to 33 K (-37.76 %) |
| Feb 24 2021 | ABBV | AbbVie Inc. | Sorg Elaine K. | SVP, US Commercial ... | Buy | M | 79.02 | 5,192 | 410,272 | 52,946 | 47.8 K to 52.9 K (+10.87 %) |
| Feb 24 2021 | ABBV | AbbVie Inc. | Sorg Elaine K. | SVP, US Commercial ... | Buy | M | 93.50 | 15,003 | 1,402,781 | 47,754 | 32.8 K to 47.8 K (+45.81 %) |
| Feb 22 2021 | ABBV | AbbVie Inc. | Gosebruch Henry O | EVP, Chief Strategy ... | Option Exercise | A | 105.92 | 49,068 | 5,197,283 | 49,068 | |
| Feb 22 2021 | ABBV | AbbVie Inc. | Gosebruch Henry O | EVP, Chief Strategy ... | Grant | A | 0.00 | 14,724 | 0 | 71,544 | 56.8 K to 71.5 K (+25.91 %) |
| Feb 22 2021 | ABBV | AbbVie Inc. | Gosebruch Henry O | EVP, Chief Strategy ... | Grant | A | 0.00 | 7,972 | 0 | 56,820 | 48.8 K to 56.8 K (+16.32 %) |
| Feb 22 2021 | ABBV | AbbVie Inc. | Gosebruch Henry O | EVP, Chief Strategy ... | Grant | A | 0.00 | 6,555 | 0 | 48,848 | 42.3 K to 48.8 K (+15.50 %) |
| Feb 22 2021 | ABBV | AbbVie Inc. | Gosebruch Henry O | EVP, Chief Strategy ... | Grant | A | 0.00 | 22,287 | 0 | 42,293 | 20 K to 42.3 K (+111.40 %) |
| Jan 05 2021 | ABBV | AbbVie Inc. | Strom Carrie C | SVP & Pres Global A ... | Payment of Exercise | F | 107.15 | 2,576 | 276,018 | 60,962 | 63.5 K to 61 K (-4.05 %) |
| Dec 31 2020 | ABBV | AbbVie Inc. | Stewart Jeffrey Ryan | EVP, Commercial Ope ... | Option Exercise | M | 51.42 | 25,290 | 1,300,412 | 0 | |
| Dec 31 2020 | ABBV | AbbVie Inc. | Stewart Jeffrey Ryan | EVP, Commercial Ope ... | Sell | S | 105.00 | 25,290 | 2,655,450 | 50,969 | 76.3 K to 51 K (-33.16 %) |
| Dec 31 2020 | ABBV | AbbVie Inc. | Stewart Jeffrey Ryan | EVP, Commercial Ope ... | Buy | M | 51.42 | 25,290 | 1,300,412 | 76,259 | 51 K to 76.3 K (+49.62 %) |
| Dec 31 2020 | ABBV | AbbVie Inc. | Schumacher Laura J | Vice Chairman | Gift | G | 0.00 | 28,950 | 0 | 177,541 | 206.5 K to 177.5 K (-14.02 %) |
| Dec 31 2020 | ABBV | AbbVie Inc. | GONZALEZ RICHARD A | Chairman of the Boa ... | Gift | G | 0.00 | 29,017 | 0 | 286,400 | 315.4 K to 286.4 K (-9.20 %) |
| Dec 11 2020 | ABBV | AbbVie Inc. | GONZALEZ RICHARD A | Chairman of the Boa ... | Gift | G | 0.00 | 3,225 | 0 | 315,417 | 318.6 K to 315.4 K (-1.01 %) |
| Dec 11 2020 | ABBV | AbbVie Inc. | Stewart Jeffrey Ryan | SVP, US Commercial ... | Payment of Exercise | F | 108.67 | 1,791 | 194,628 | 50,969 | 52.8 K to 51 K (-3.39 %) |
| Dec 01 2020 | ABBV | AbbVie Inc. | RICHMOND TIMOTHY J. | EVP, Chief HR Offic ... | Option Exercise | M | 51.42 | 51,990 | 2,673,326 | 0 | |
| Dec 01 2020 | ABBV | AbbVie Inc. | RICHMOND TIMOTHY J. | EVP, Chief HR Offic ... | Sell | S | 105.00 | 51,990 | 5,458,950 | 0 | 52 K to 0 (-100.00 %) |
| Dec 01 2020 | ABBV | AbbVie Inc. | RICHMOND TIMOTHY J. | EVP, Chief HR Offic ... | Buy | M | 51.42 | 51,990 | 2,673,326 | 51,990 | 0 to 52 K |
| Nov 24 2020 | ABBV | AbbVie Inc. | Gosebruch Henry O | EVP, Chief Strategy ... | Sell | S | 99.49 | 33,100 | 3,293,119 | 20,006 | 53.1 K to 20 K (-62.33 %) |
| Nov 24 2020 | ABBV | AbbVie Inc. | Gosebruch Henry O | EVP, Chief Strategy ... | Sell | S | 98.83 | 6,900 | 681,927 | 53,106 | 60 K to 53.1 K (-11.50 %) |
| Nov 18 2020 | ABBV | AbbVie Inc. | ALBAN CARLOS | Vice Chairman | Option Exercise | M | 35.88 | 115,830 | 4,155,980 | 0 | |
| Nov 18 2020 | ABBV | AbbVie Inc. | ALBAN CARLOS | Vice Chairman | Sell | S | 100.00 | 115,830 | 11,583,000 | 114,899 | 230.7 K to 114.9 K (-50.20 %) |
| Nov 18 2020 | ABBV | AbbVie Inc. | ALBAN CARLOS | Vice Chairman | Buy | M | 35.88 | 115,830 | 4,155,980 | 230,729 | 114.9 K to 230.7 K (+100.81 %) |
| Nov 12 2020 | ABBV | AbbVie Inc. | SALEKI-GERHARDT AZITA | EVP, Operations | Sell | S | 98.00 | 17,426 | 1,707,748 | 96,441 | 113.9 K to 96.4 K (-15.30 %) |
| Nov 12 2020 | ABBV | AbbVie Inc. | GONZALEZ RICHARD A | Chairman of the Boa ... | Option Exercise | M | 58.88 | 109,097 | 6,423,631 | 0 | |
| Nov 12 2020 | ABBV | AbbVie Inc. | GONZALEZ RICHARD A | Chairman of the Boa ... | Option Exercise | M | 54.86 | 85,057 | 4,666,227 | 170,113 | |
| Nov 12 2020 | ABBV | AbbVie Inc. | GONZALEZ RICHARD A | Chairman of the Boa ... | Sell | S | 97.49 | 16,171 | 1,576,493 | 318,642 | 334.8 K to 318.6 K (-4.83 %) |
| Nov 12 2020 | ABBV | AbbVie Inc. | GONZALEZ RICHARD A | Chairman of the Boa ... | Sell | S | 97.06 | 177,983 | 17,275,297 | 334,813 | 512.8 K to 334.8 K (-34.71 %) |
| Nov 12 2020 | ABBV | AbbVie Inc. | GONZALEZ RICHARD A | Chairman of the Boa ... | Buy | M | 58.88 | 109,097 | 6,423,631 | 512,796 | 403.7 K to 512.8 K (+27.02 %) |
| Nov 12 2020 | ABBV | AbbVie Inc. | GONZALEZ RICHARD A | Chairman of the Boa ... | Buy | M | 54.86 | 85,057 | 4,666,227 | 403,699 | 318.6 K to 403.7 K (+26.69 %) |
| Nov 12 2020 | ABBV | AbbVie Inc. | GONZALEZ RICHARD A | Chairman of the Boa ... | Sell | S | 95.74 | 37,450 | 3,585,463 | 318,642 | 356.1 K to 318.6 K (-10.52 %) |
| Nov 06 2020 | ABBV | AbbVie Inc. | SEVERINO MICHAEL | Vice Chairman | Sell | S | 93.61 | 90,679 | 8,488,461 | 67,281 | 158 K to 67.3 K (-57.41 %) |
| Nov 06 2020 | ABBV | AbbVie Inc. | SALEKI-GERHARDT AZITA | EVP, Operations | Sell | S | 93.61 | 4,800 | 449,328 | 109,067 | 113.9 K to 109.1 K (-4.22 %) |
| Oct 02 2020 | ABBV | AbbVie Inc. | RAPP EDWARD J | Director | Option Exercise | A | 0.00 | 402 | 0 | 18,735 | |
| Oct 02 2020 | ABBV | AbbVie Inc. | RAPP EDWARD J | Director | Gift | G | 0.00 | 7,513 | 0 | 10,388 | 2.9 K to 10.4 K (+261.32 %) |
| Oct 02 2020 | ABBV | AbbVie Inc. | RAPP EDWARD J | Director | Gift | G | 0.00 | 7,513 | 0 | 25,482 | 33 K to 25.5 K (-22.77 %) |
| Oct 02 2020 | ABBV | AbbVie Inc. | RAPP EDWARD J | Director | Option Exercise | A | 0.00 | 402 | 0 | 18,735 | |
| Oct 02 2020 | ABBV | AbbVie Inc. | RAPP EDWARD J | Director | Gift | G | 0.00 | 7,513 | 0 | 10,388 | 2.9 K to 10.4 K (+261.32 %) |
| Oct 02 2020 | ABBV | AbbVie Inc. | RAPP EDWARD J | Director | Gift | G | 0.00 | 7,513 | 0 | 25,482 | 33 K to 25.5 K (-22.77 %) |
| Oct 02 2020 | ABBV | AbbVie Inc. | Alpern Robert J | Director | Option Exercise | A | 0.00 | 82 | 0 | 7,489 | |
| Oct 02 2020 | ABBV | AbbVie Inc. | LIDDY EDWARD M | Director | Option Exercise | A | 0.00 | 385 | 0 | 26,908 | |
| Oct 02 2020 | ABBV | AbbVie Inc. | Alpern Robert J | Director | Option Exercise | A | 0.00 | 82 | 0 | 7,489 | |
| Oct 02 2020 | ABBV | AbbVie Inc. | LIDDY EDWARD M | Director | Option Exercise | A | 0.00 | 385 | 0 | 26,908 | |
| Jul 08 2020 | ABBV | AbbVie Inc. | ALBAN CARLOS | Vice Chairman | Sell | S | 100.00 | 23,000 | 2,300,000 | 114,899 | 137.9 K to 114.9 K (-16.68 %) |
| Jul 08 2020 | ABBV | AbbVie Inc. | ALBAN CARLOS | Vice Chairman | Sell | S | 100.00 | 30,325 | 3,032,555 | 137,899 | 168.2 K to 137.9 K (-18.03 %) |
| Jul 02 2020 | ABBV | AbbVie Inc. | RAPP EDWARD J | Director | Option Exercise | A | 0.00 | 350 | 0 | 18,108 | |
| Jul 02 2020 | ABBV | AbbVie Inc. | LIDDY EDWARD M | Director | Option Exercise | A | 0.00 | 335 | 0 | 26,288 | |
| Jul 02 2020 | ABBV | AbbVie Inc. | Alpern Robert J | Director | Option Exercise | A | 0.00 | 71 | 0 | 7,353 | |
| May 12 2020 | ABBV | AbbVie Inc. | FREYMAN THOMAS C | Director | Grant | A | 0.00 | 2,333 | 0 | 119,675 | 117.3 K to 119.7 K (+1.99 %) |
| May 12 2020 | ABBV | AbbVie Inc. | FREYMAN THOMAS C | Director | Grant | A | 0.00 | 2,583 | 0 | 117,342 | 114.8 K to 117.3 K (+2.25 %) |
| May 12 2020 | ABBV | AbbVie Inc. | Strom Carrie C | SVP & Pres Global A ... | Option Exercise | A | 65.45 | 3,613 | 236,471 | 3,613 | |
| May 12 2020 | ABBV | AbbVie Inc. | Strom Carrie C | SVP & Pres Global A ... | Option Exercise | A | 104.04 | 3,440 | 357,898 | 3,440 | |
| May 12 2020 | ABBV | AbbVie Inc. | Strom Carrie C | SVP & Pres Global A ... | Option Exercise | A | 123.51 | 2,567 | 317,050 | 2,567 | |
| May 12 2020 | ABBV | AbbVie Inc. | Strom Carrie C | SVP & Pres Global A ... | Option Exercise | A | 133.53 | 2,017 | 269,330 | 2,017 | |
| May 12 2020 | ABBV | AbbVie Inc. | Strom Carrie C | SVP & Pres Global A ... | Option Exercise | A | 125.82 | 5,729 | 720,823 | 5,729 | |
| May 12 2020 | ABBV | AbbVie Inc. | Strom Carrie C | SVP & Pres Global A ... | Option Exercise | A | 67.25 | 6,370 | 428,383 | 6,370 | |
| May 12 2020 | ABBV | AbbVie Inc. | Strom Carrie C | SVP & Pres Global A ... | Option Exercise | A | 56.93 | 7,809 | 444,566 | 7,809 | |
| May 12 2020 | ABBV | AbbVie Inc. | Strom Carrie C | SVP & Pres Global A ... | Option Exercise | A | 47.27 | 4,184 | 197,778 | 4,184 | |
| May 12 2020 | ABBV | AbbVie Inc. | Strom Carrie C | SVP & Pres Global A ... | Option Exercise | A | 41.39 | 4,184 | 173,176 | 4,184 | |
| May 12 2020 | ABBV | AbbVie Inc. | Strom Carrie C | SVP & Pres Global A ... | Grant | A | 0.00 | 23,196 | 0 | 63,538 | 40.3 K to 63.5 K (+57.50 %) |
| May 12 2020 | ABBV | AbbVie Inc. | Strom Carrie C | SVP & Pres Global A ... | Grant | A | 0.00 | 37,903 | 0 | 40,342 | 2.4 K to 40.3 K (+1,554.04 %) |
| May 12 2020 | ABBV | AbbVie Inc. | Strom Carrie C | SVP & Pres Global A ... | Grant | A | 0.00 | 2,439 | 0 | 2,439 | 0 to 2.4 K |
| May 12 2020 | ABBV | AbbVie Inc. | GONZALEZ RICHARD A | Chairman of the Boa ... | Gift | G | 0.00 | 5,450 | 0 | 5,900 | 450 to 5.9 K (+1,211.11 %) |
| May 12 2020 | ABBV | AbbVie Inc. | GONZALEZ RICHARD A | Chairman of the Boa ... | Gift | G | 0.00 | 5,450 | 0 | 5,900 | 450 to 5.9 K (+1,211.11 %) |
| May 12 2020 | ABBV | AbbVie Inc. | GONZALEZ RICHARD A | Chairman of the Boa ... | Gift | G | 0.00 | 10,900 | 0 | 17,615 | 6.7 K to 17.6 K (+162.32 %) |
| May 12 2020 | ABBV | AbbVie Inc. | GONZALEZ RICHARD A | Chairman of the Boa ... | Gift | G | 0.00 | 21,800 | 0 | 356,092 | 377.9 K to 356.1 K (-5.77 %) |
| May 12 2020 | ABBV | AbbVie Inc. | Stewart Jeffrey Ryan | SVP, US Commercial ... | Sell | S | 90.00 | 23,024 | 2,072,211 | 52,760 | 75.8 K to 52.8 K (-30.38 %) |
| May 12 2020 | ABBV | AbbVie Inc. | Durkin Brian L | VP, Controller | Grant | A | 0.00 | 60 | 0 | 17,704 | 17.6 K to 17.7 K (+0.34 %) |
| May 12 2020 | ABBV | AbbVie Inc. | RAPP EDWARD J | Director | Grant | A | 0.00 | 2,333 | 0 | 32,995 | 30.7 K to 33 K (+7.61 %) |
| May 12 2020 | ABBV | AbbVie Inc. | WADDELL FREDERICK H | Director | Grant | A | 0.00 | 2,333 | 0 | 21,881 | 19.5 K to 21.9 K (+11.93 %) |
| May 12 2020 | ABBV | AbbVie Inc. | TILTON GLENN F | Director | Grant | A | 0.00 | 2,333 | 0 | 44,487 | 42.2 K to 44.5 K (+5.53 %) |
| May 12 2020 | ABBV | AbbVie Inc. | Roberts Rebecca B | Director | Grant | A | 0.00 | 2,333 | 0 | 6,651 | 4.3 K to 6.7 K (+54.03 %) |
| May 12 2020 | ABBV | AbbVie Inc. | MEYER MELODY B | Director | Grant | A | 0.00 | 2,333 | 0 | 9,421 | 7.1 K to 9.4 K (+32.91 %) |
| May 12 2020 | ABBV | AbbVie Inc. | LIDDY EDWARD M | Director | Grant | A | 0.00 | 2,333 | 0 | 25,002 | 22.7 K to 25 K (+10.29 %) |
| May 12 2020 | ABBV | AbbVie Inc. | BURNSIDE WILLIAM H.L. | Director | Grant | A | 0.00 | 2,333 | 0 | 19,881 | 17.5 K to 19.9 K (+13.29 %) |
| May 12 2020 | ABBV | AbbVie Inc. | AUSTIN ROXANNE S | Director | Grant | A | 0.00 | 2,333 | 0 | 119,447 | 117.1 K to 119.4 K (+1.99 %) |
| May 12 2020 | ABBV | AbbVie Inc. | Alpern Robert J | Director | Grant | A | 0.00 | 2,333 | 0 | 28,440 | 26.1 K to 28.4 K (+8.94 %) |
| May 07 2020 | ABBV | AbbVie Inc. | RICHMOND TIMOTHY J. | EVP, Chief HR Offic ... | Sell | S | 85.00 | 19,445 | 1,652,825 | 0 | 19.4 K to 0 (-100.00 %) |
| Apr 24 2020 | ABBV | AbbVie Inc. | Gosebruch Henry O | EVP, Chief Strategy ... | Gift | G | 0.00 | 18,500 | 0 | 48,500 | 30 K to 48.5 K (+61.67 %) |
| Apr 24 2020 | ABBV | AbbVie Inc. | Gosebruch Henry O | EVP, Chief Strategy ... | Gift | G | 0.00 | 18,500 | 0 | 60,006 | 78.5 K to 60 K (-23.57 %) |
| Apr 24 2020 | ABBV | AbbVie Inc. | Schumacher Laura J | Vice Chairman | Gift | G | 0.00 | 410 | 0 | 206,491 | 206.9 K to 206.5 K (-0.20 %) |
| Apr 02 2020 | ABBV | AbbVie Inc. | RAPP EDWARD J | Director | Option Exercise | A | 0.00 | 446 | 0 | 17,530 | |
| Apr 02 2020 | ABBV | AbbVie Inc. | LIDDY EDWARD M | Director | Option Exercise | A | 0.00 | 426 | 0 | 25,428 | |
| Apr 02 2020 | ABBV | AbbVie Inc. | Alpern Robert J | Director | Option Exercise | A | 0.00 | 90 | 0 | 7,110 | |
| Apr 02 2020 | ABBV | AbbVie Inc. | GONZALEZ RICHARD A | Chairman of the Boa ... | Gift | G | 0.00 | 56,950 | 0 | 377,892 | 434.8 K to 377.9 K (-13.10 %) |
| Mar 20 2020 | ABBV | AbbVie Inc. | Durkin Brian L | VP, Controller | Buy | P | 69.00 | 750 | 51,750 | 16,844 | 16.1 K to 16.8 K (+4.66 %) |
| Mar 20 2020 | ABBV | AbbVie Inc. | Durkin Brian L | VP, Controller | Buy | P | 67.50 | 800 | 54,000 | 16,094 | 15.3 K to 16.1 K (+5.23 %) |
| Mar 20 2020 | ABBV | AbbVie Inc. | Durkin Brian L | VP, Controller | Buy | P | 68.18 | 2,200 | 150,005 | 15,294 | 13.1 K to 15.3 K (+16.80 %) |
| Mar 04 2020 | ABBV | AbbVie Inc. | RAPP EDWARD J | Director | Buy | P | 87.87 | 2,875 | 252,617 | 2,875 | 0 to 2.9 K |
| Mar 03 2020 | ABBV | AbbVie Inc. | Stewart Jeffrey Ryan | SVP, US Commercial ... | Payment of Exercise | F | 85.42 | 9,703 | 828,830 | 75,784 | 85.5 K to 75.8 K (-11.35 %) |
| Mar 03 2020 | ABBV | AbbVie Inc. | SEVERINO MICHAEL | Vice Chairman | Payment of Exercise | F | 85.42 | 33,492 | 2,860,887 | 157,960 | 191.5 K to 158 K (-17.49 %) |
| Mar 03 2020 | ABBV | AbbVie Inc. | Schumacher Laura J | Vice Chairman | Payment of Exercise | F | 85.42 | 33,745 | 2,882,498 | 206,901 | 240.6 K to 206.9 K (-14.02 %) |
| Mar 03 2020 | ABBV | AbbVie Inc. | SALEKI-GERHARDT AZITA | EVP, Operations | Payment of Exercise | F | 85.42 | 16,342 | 1,395,934 | 113,867 | 130.2 K to 113.9 K (-12.55 %) |
| Mar 03 2020 | ABBV | AbbVie Inc. | Hudson Thomas J | SVP, R&D and CSO | Payment of Exercise | F | 85.42 | 5,477 | 467,845 | 19,643 | 25.1 K to 19.6 K (-21.80 %) |
| Mar 03 2020 | ABBV | AbbVie Inc. | Hudson Thomas J | SVP, R&D and CSO | Payment of Exercise | F | 85.42 | 5,477 | 467,845 | 19,643 | 25.1 K to 19.6 K (-21.80 %) |
| Mar 03 2020 | ABBV | AbbVie Inc. | Gosebruch Henry O | EVP, Chief Strategy ... | Payment of Exercise | F | 85.42 | 26,038 | 2,224,166 | 78,506 | 104.5 K to 78.5 K (-24.91 %) |
| Mar 03 2020 | ABBV | AbbVie Inc. | Gosebruch Henry O | EVP, Chief Strategy ... | Payment of Exercise | F | 85.42 | 26,038 | 2,224,166 | 78,506 | 104.5 K to 78.5 K (-24.91 %) |
| Mar 03 2020 | ABBV | AbbVie Inc. | GONZALEZ RICHARD A | Chairman of the Boa ... | Payment of Exercise | F | 85.42 | 88,719 | 7,578,377 | 434,842 | 523.6 K to 434.8 K (-16.95 %) |
| Mar 03 2020 | ABBV | AbbVie Inc. | GONZALEZ RICHARD A | Chairman of the Boa ... | Payment of Exercise | F | 85.42 | 88,719 | 7,578,377 | 434,842 | 523.6 K to 434.8 K (-16.95 %) |
| Mar 03 2020 | ABBV | AbbVie Inc. | Durkin Brian L | VP, Controller | Payment of Exercise | F | 85.42 | 1,941 | 165,800 | 13,094 | 15 K to 13.1 K (-12.91 %) |
| Mar 03 2020 | ABBV | AbbVie Inc. | Durkin Brian L | VP, Controller | Payment of Exercise | F | 85.42 | 1,941 | 165,800 | 13,094 | 15 K to 13.1 K (-12.91 %) |
| Mar 03 2020 | ABBV | AbbVie Inc. | Donoghoe Nicholas | SVP, Enterprise Inn ... | Payment of Exercise | F | 85.42 | 2,355 | 201,164 | 15,149 | 17.5 K to 15.1 K (-13.45 %) |
| Mar 03 2020 | ABBV | AbbVie Inc. | Donoghoe Nicholas | SVP, Enterprise Inn ... | Payment of Exercise | F | 85.42 | 2,355 | 201,164 | 15,149 | 17.5 K to 15.1 K (-13.45 %) |